News|Videos|August 31, 2023
Chapter 6. Optimizing the Duration of Effect with Stimulant Medications
Sponsored by: Ironshore Pharmaceuticals
Episodes in this series
IP001858 08/23
Related Content
Latest CME
Trending on Psychiatric Times
1
FDA Issues CRL for CTx-1301 for Treatment of ADHD
2
Insights Into Mechanism-Based Biomarkers for Psychosis Prediction from Kim Do, PhD
3
New Name, New Path for Psychiatry: The Future of the DSM
4
Nonpharmacological Augmentation of Ketamine, Neuroplasticity, and Behavioral Therapy
5